Deutivacaftor
Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...

Impressions : 1462